Livzon Pharmaceutical Group Inc. (SHE:000513)
34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST
2.16% (1Y)
| Market Cap | 27.74B +0.3% |
| Revenue (ttm) | 12.02B +1.8% |
| Net Income | 2.02B -1.8% |
| EPS | 2.27 +1.2% |
| Shares Out | 887.91M |
| PE Ratio | 15.07 |
| Forward PE | 14.59 |
| Dividend | 1.43 (4.15%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 6,208,315 |
| Average Volume | 5,673,168 |
| Open | 34.50 |
| Previous Close | 34.15 |
| Day's Range | 34.13 - 34.58 |
| 52-Week Range | 32.45 - 44.87 |
| Beta | 0.38 |
| RSI | 49.71 |
| Earnings Date | Mar 24, 2026 |